HUMAN URINARY-EXCRETION PROFILE AFTER SMOKING AND ORAL-ADMINISTRATION OF [C-14] DELTA-1-TETRAHYDROCANNABINOL

被引:17
作者
JOHANSSON, E
GILLESPIE, HK
HALLDIN, MM
机构
[1] KAROLINSKA INST, DEPT PHARMACOL, S-10401 STOCKHOLM 60, SWEDEN
[2] BIOMED CTR, DEPT PHARMACOGNOSY, S-75123 UPPSALA, SWEDEN
[3] HARRIS CTY PSYCHIAT CTR, HOUSTON, TX 77225 USA
关键词
D O I
10.1093/jat/14.3.176
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The urinary excretion profiles of Δ1-tetrahydrocannabinol (Δ1-THC) metabolites have been evaluated in two chronic and two naive marijuana users after smoking and oral administration of [14C]Δ1-THC. Urine was collected for five days after each administration route and analyzed for total Δ1-THC metabolites by radioactivity determination, for Δ1-THC-7-oic acid by high-performance liquid chromatography, and for cross-reacting cannabinoids by the EMIT d.a.u. cannabinoid assay. The average urinary excretion half-life of 14C-labeled Δ1-THC metabolites was calculated to be 18.2 ± 4.9 h (± SD). The excretion profiles of Δ1-THC-7-oic acid and EMIT readings were similar to the excretion profile of 14C-labeled metabolites in the naive users. However, in the chronic users the excretion profiles of Δ1-THC-7-oic acid and EMIT readings did not resemble the radioactive excretion due to the heavy influence from previous Cannabis use. Between 8–14% of the radioactive dose was recovered in the urine in both user groups after oral administration. Lower urinary recovery was obtained both in the chronic and naive users after smoking—5 and 2%, respectively. © 1989 Oxford University Press.
引用
收藏
页码:176 / 180
页数:5
相关论文
共 23 条
[1]  
AGURELL S, 1986, PHARMACOL REV, V38, P21
[2]  
COOK E, 1986, ALCOHOL DRUGS DRIVIN, V2, P79
[3]   APPARENT HALF-LIFE OF EXCRETION OF CANNABINOIDS IN MAN [J].
CRIDLAND, JS ;
ROTTANBURG, D ;
ROBINS, AH .
HUMAN TOXICOLOGY, 1983, 2 (04) :641-644
[4]  
DeLaurentis M J, 1982, NIDA Res Monogr, V42, P69
[5]   EXCRETION PATTERNS OF CANNABINOID METABOLITES AFTER LAST USE IN A GROUP OF CHRONIC USERS [J].
ELLIS, GM ;
MANN, MA ;
JUDSON, BA ;
SCHRAMM, NT ;
TASHCHIAN, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :572-578
[6]  
HALLDIN MM, 1982, ARZNEIMITTEL-FORSCH, V32-2, P764
[7]  
HALLDIN MM, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1135
[8]  
HOLLISTER LE, 1974, RES COMMUN CHEM PATH, V8, P579
[9]   EVALUATION OF IMMUNOASSAYS FOR CANNABINOIDS IN URINE [J].
IRVING, J ;
LEEB, B ;
FOLTZ, RL ;
COOK, CE ;
BURSEY, JT ;
WILLETTE, RE .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1984, 8 (04) :192-196